Content and quality of clinical practice guidelines for the management of type 2 diabetes in India: A systematic review.
Content and quality of clinical practice guidelines for the management of type 2 diabetes in India: A systematic review.
复制标题
DOI：
10.1002/edm2.405
复制
发表时间：
2023-03
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
在过去的几十年里，印度见证了2型糖尿病(T2 DM)患者数量的增加。因此，一些临床实践指南(CPGs)已经被开发出来，以帮助西医和传统的印度医生管理这种疾病。本次系统评价的目的是评价和综合这些CPG的内容和质量。从最初到2022年5月，搜索了几个数据库和来源，以确定用于管理印度成年T2 DM患者的CPG。标题和摘要以及全文的筛选、数据提取和质量评估由两名独立审查员进行。任何分歧都是通过讨论或让第三位审查员参与解决的。采用先前研究中的数据提取工具来提取所纳入的国家方案小组的内容，并使用第二次研究和评价准则评估工具来评估所纳入的国家方案小组的质量。进行了叙事综合。在确认的3350份记录中，检索了11份以进行全文筛选，5份CPG被纳入这项系统审查--3份侧重于印度传统医学(阿育吠陀)，2份侧重于西医。这两个西药CPG包含了治疗T2 DM的全面建议，但其中只有一个，印度糖尿病研究学会/印度内分泌学会(RSSDI/ESI)CPG是高质量的。在印度，西医只能推荐一种CPG来治疗T2 DM。应使用标准的CPG手册和质量评估工具制定和更新未来的CPG，特别是针对印度传统医药从业者的CPG。Propero(CRD42021279499)。在印度，我们发现了三个关于印度传统医学(阿育吠陀)的临床实践指南(CPG)和两个关于西医的临床实践指南(CPG)。这两个西药CPG包含了治疗2型糖尿病(T2 DM)的全面建议，但其中只有一个是高质量的，即印度糖尿病研究学会/印度内分泌学会(RSSDI/ESI)CPG。在印度，西医只能推荐一种CPG来治疗T2 DM。应使用标准的CPG手册和质量评估工具制定和更新未来的CPG，特别是针对印度传统医药从业者的CPG。
Over the last few decades, India has witnessed an increase in the number of people with type 2 diabetes mellitus (T2DM). Consequently, several clinical practice guidelines (CPGs) have been developed to assist western and traditional Indian medicine practitioners in managing this disease. This systematic review aimed to evaluate and synthesize the content and quality of these CPGs. Several databases and sources were searched from inception to May 2022, to identify CPGs for managing adults with T2DM in India. The screening of titles and abstracts and full texts, data extraction and quality assessment were conducted by two independent reviewers. Any disagreements were resolved through discussion or by involving a third reviewer. A data extraction tool from a previous study was adapted to extract the content of the included CPGs, and the Appraisal of Guidelines for Research and Evaluation II tool was used to assess the quality of the included CPGs. A narrative synthesis was conducted. Of 3350 records identified, 11 were retrieved for full‐text screening and five CPGs were included in this systematic review—three focused on traditional Indian medicine (Ayurveda) and two focused on western medicine. These two western medicine CPGs contained comprehensive recommendations for managing T2DM but only one of these, the Research Society for the Study of Diabetes in India/Endocrine Society of India (RSSDI/ESI) CPG, was of high quality. Only one CPG can be recommended for managing T2DM by western medicine practitioners in India. Future CPGs, especially for traditional Indian medicine practitioners, should be developed and updated using the standard CPG manuals and quality appraisal tools. PROSPERO (CRD42021279499). In India, we found three clinical practice guidelines (CPGs) on traditional Indian medicine (Ayurveda) and two on western medicine. These two western medicine CPGs contain comprehensive recommendations for managing type 2 diabetes mellitus (T2DM) but only one of these, the Research Society for the Study of Diabetes in India/Endocrine Society of India (RSSDI/ESI) CPG, is of high quality. Only one CPG can be recommended for managing T2DM by western medicine practitioners in India. Future CPGs, especially for traditional Indian medicine practitioners, should be developed and updated using the standard CPG manuals and quality appraisal tools.